Name

AIDA

Alternate names

None

Primary Site

None

Histology

None

Radiation

None

Remarks

None

Drugs for AIDA

Name

Alternate Names

Aberel
Airol
All-trans-retinoic acid
Avita
Dermairol
Eudyna
Renova
Retin-A
Retinoic acid
Retisol-A
Stieva-A
Vesanoid
Vitamin A Acid
Vitinoin

Abbreviations

ATRA
Vit A

Category

Differentiation inducing agent

Subcategory

None

NSC Number

122758

Primary Site

Acute Promyelocytic leukemia (APL)
AIDS

Histology

None

Remarks

Tretinoin is FDA approved for treatment of acute promyelocytic leukemia (APL). It is a retinoid/differentiation agent and at this time the precise mechanism of action has not been fully elucidated so it cannot be assigned to chemotherapy, hormone or BRM/immunotherapy. Code this agent as treatment in the "Other Therapy" data field (using code 1).

Phase II (head & neck)
Administered topically, tretinoin stimulates epithelial turnover and reduces epithelial cell cohesiveness. Under investigation for treatment of Kaposi sarcoma lesions. FDA approved therapy of acute promyelocytic leukemia. NCI.Code this agent as treatment in the "Other Therapy" data field (using code 1).

Coding

Please see remarks for additional information

Name

Alternate Names

4-Demethoxydaunorubicin
Idamycin
Idamycin PFS
Idarubicin hydrochloride
IMI 30
IMI-30
SC-33428

Abbreviations

4-DMDR
IDA

Category

Chemotherapy

Subcategory

Antitumor antibiotic

NSC Number

256439

Primary Site

Acute lymphoblastic leukemia (ALL)
Chronic myelogenous leukemia in blast crises
Myelodysplastic syndromes (MDS)

Histology

None

Remarks

An anthracycline antineoplastic agent. FDA approved uses on acute lymphocytic and non-lymphcytic leukemia.

Coding

This drug should be coded
Glossary